downloaded from on may 17, 2020 by guest€¦ · 04/05/2012 · 10 laboratory of microbial...
TRANSCRIPT
1
Development of a double-crossover markerless gene deletion system in 1
Bifidobacterium longum: Functional analysis of the α-galactosidase 2
gene for raffinose assimilation 3
4
Running title: Markerless gene deletion in B. longum 5
6
Yosuke Hirayama,1 Mikiyasu Sakanaka,1 Hidenori Fukuma,2 Hiroki Murayama,2 7
Yasunobu Kano,2 Satoru Fukiya,1* and Atsushi Yokota1 8
9
Laboratory of Microbial Physiology, Research Faculty of Agriculture, Hokkaido 10
University, Kita 9 Nishi 9, Kita-ku, Sapporo, Hokkaido 060-8589, Japan1; Department 11
of Molecular Genetics, Kyoto Pharmaceutical University, 5, Nakauchi-cho, Misasagi, 12
Yamashina-ku, Kyoto 607-8414, Japan2 13
14
*Corresponding author. Mailing address: Laboratory of Microbial Physiology, 15
Research Faculty of Agriculture, Hokkaido University, Kita 9 Nishi 9, Kita-ku, 16
Sapporo, Hokkaido 060-8589, Japan. Phone/Fax: +81-11-706-2501. E-mail: 17
19
Copyright © 2012, American Society for Microbiology. All Rights Reserved.Appl. Environ. Microbiol. doi:10.1128/AEM.00588-12 AEM Accepts, published online ahead of print on 11 May 2012
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
2
ABSTRACT 20
Functional analysis of Bifidobacterium genes is essential for understanding 21
host-Bifidobacterium interactions with beneficial effects on human health; however, 22
lack of an effective targeted gene inactivation system in bifidobacteria has prevented 23
the development of functional genomics in this bacterium. Here, we report the 24
development of a markerless gene deletion system involving a double crossover in 25
Bifidobacterium longum. Incompatible plasmid vectors were used to facilitate a second 26
crossover step. The conditional replication vector pBS423-ΔrepA, which lacks the 27
plasmid replication gene repA, was integrated into the target gene by a first crossover 28
event. Subsequently, the replicative plasmid pTBR101-CM, which harbors repA, was 29
introduced into this integrant in order to facilitate the second crossover step and 30
subsequent elimination of the excised conditional replication vector from the cells by 31
the plasmid incompatibility. The proposed system was confirmed to work as expected 32
in B. longum 105-A using the chromosomal full-length β-galactosidase gene as a target. 33
Then, markerless gene deletion was tested using the aga gene, which encodes 34
α-galactosidase, whose substrates include raffinose. Almost all the 35
pTBR101-CM-transformed strains became double-crossover recombinants after 36
subculture, and four out of the 270 double-crossover recombinants had lost the ability 37
to assimilate raffinose. Genotype analysis of these strains revealed markerless gene 38
deletion of aga. Carbohydrate assimilation analysis and α-galactosidase activity 39
measurement were conducted using both the representative mutant and a 40
plasmid-based aga-complemented strain. These functional analyses revealed that aga 41
is the only gene encoding a functional α-galactosidase enzyme in B. longum 105-A. 42
43
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
3
INTRODUCTION 44
Bifidobacteria are generally known as beneficial microbes that produce 45
health-promoting effects by interacting with their hosts (20, 23). Some bifidobacteria 46
are commercially used as probiotics in yogurt products and as pharmaceutical agents. 47
To better understand bifidobacteria, the genome sequences of several probiotic 48
bifidobacterial species—Bifidobacterium longum NCC2705 (46), B. longum DJO10A 49
(26), B. longum subsp. infantis ATCC15697 (47), Bifidobacterium breve UCC2003 50
(34), and Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04 (4)—have 51
been analyzed. Although knowledge of the genome sequences enables the prediction of 52
bifidobacterial gene function, clarification of the detailed mechanisms of interactions is 53
not possible with genomic information alone. The most effective approach for directly 54
analyzing gene function is targeted gene mutagenesis. However, this approach is still 55
not easily applicable to studies of bifidobacteria (14), despite recent progress (15, 56
32-34, 41). 57
Currently, Escherichia coli-Bifidobacterium shuttle vectors based on cryptic 58
plasmids have been developed, but they have relatively low transformation frequencies 59
(14). As for gene mutagenesis systems, the construction of vector-insertion mutants by 60
single crossover and gene disruption mutants by double crossover through allelic 61
exchange between drug resistance genes and target genes have been reported (15, 62
32-34, 41). Markerless gene deletion, which leaves no exogenous DNA in mutated 63
alleles, has not yet been achieved in bifidobacteria. Markerless gene deletion has 64
several advantages: i) it is stable; ii) it avoids polar effects on the expression of 65
adjacent genes; and iii) it enables multiple gene deletions in a genome. 66
Markerless gene deletion using the double-crossover method has been achieved in 67
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
4
various bacteria (19, 28, 31, 35, 38). Generally, a low frequency of the second 68
crossover event is an obstacle to successful gene deletion, and strategies for efficiently 69
selecting second-crossover recombinants are required. Conditional replication vectors 70
such as thermosensitive replication vectors (7, 17, 35, 45) and counter-selectable 71
marker genes, e.g., sacB (31, 35, 38) and pheS encoding phenylalanyl-tRNA synthase 72
α-subunit (5, 50), have been used to overcome this problem in other bacteria. A similar 73
system should be applicable in bifidobacteria, but reliable conditional replication 74
vectors and suitable counter-selectable marker genes are currently unavailable. 75
To achieve markerless gene deletion in the bifidobacterial genome, a strategy based 76
on conditional plasmid replication was conceived (Fig. 1). The plasmid for the first 77
crossover functions as a conditional replication vector as a result of deletion of the 78
gene encoding the replication protein RepA. This plasmid can only replicate in 79
bifidobacterial cells when RepA is provided in trans. When this plasmid is integrated 80
into the target gene, supplying RepA is expected to induce the conditional replication 81
of the integrated plasmid. This will result in the severe growth defects (17), 82
presumably due to the interference with chromosome replication as replication starts 83
from not only the chromosome’s origin of replication but also the origin in the 84
integrated plasmid. Under these conditions, the only cells in which a second crossover 85
has occurred, excising the integrated plasmid from the chromosome and leaving only 86
the chromosomal replication origin, can survive. To supply RepA, a second plasmid 87
harboring the repA gene is introduced into first-crossover integrants. Second-crossover 88
recombinants that lost the first plasmid can be efficiently isolated through selection 89
with appropriate antibiotics, as the second plasmid is incompatible with the conditional 90
replication vector. In this study, the proposed strategy was tested to introduce 91
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
5
markerless gene deletion in B. longum 105-A chromosome using aga gene, which 92
encodes α-galactosidase (α-Gal), as a target. 93
94
MATERIALS AND METHODS 95
Bacterial strains, plasmids and culture conditions. The bacterial strains and 96
plasmids used in this study are listed in Table 1. All chemicals were of analytical grade 97
and were commercially available. Cultures of B. longum 105-A (29) were routinely 98
grown in half-strength (1/2) MRS broth containing glucose as the fermentable 99
carbohydrate source (Becton, Dickinson and Co., Franklin Lakes, NJ) (22) and 100
supplemented with 0.02% (w/v) L-cysteine and 0.34% (w/v) sodium ascorbate (1/2 101
MRSCS). Carbohydrate assimilation by B. longum was examined in semi-synthetic 102
medium (SSM) containing raffinose, melibiose, or glucose as the sole carbohydrate 103
source (20 g/L) (39). The SSM, which did not contain L-tryptophan and L-asparagine, 104
was autoclaved at 110°C for 10 min, and then its pH was adjusted to pH 6.8 with 105
NaOH. Bacterial growth was monitored by measuring the optical density at 660 nm 106
(OD660) using a Mini Photo 518R (Taitec, Saitama, Japan) or UV-1800 (Shimadzu, 107
Kyoto, Japan) spectrophotometer. When necessary, the following antibiotics were 108
added to both the broth and the agar medium: ampicillin (100 µg/ml), chloramphenicol 109
[Cm (2.5 µg/ml)], rifampicin [Rif (0.1 µg/ml)], and spectinomycin [Spc (75 µg/ml)]. 110
Bifidobacterial strains were cultured at 37°C under anaerobic conditions in an 111
anaerobic chamber (80:10:10, N2:CO2:H2; Coy Laboratory Products, Inc., Grass Lake, 112
MI). Cultures of E. coli were grown aerobically in Luria-Bertani (LB) medium or SOC 113
medium as described previously (44). 114
115
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
6
DNA manipulations. The oligonucleotide primers used in this study are listed in 116
Supplemental Table S1. Reagents used in molecular biological procedures were 117
purchased from Takara Bio, Inc. (Otsu, Japan) unless otherwise indicated. 118
Chromosomal DNA was purified from cultured bifidobacterial cells using a previously 119
described method (13) with one modification: prior to the extraction of chromosomal 120
DNA using ISOPLANT II (Nippon Gene Co., Ltd., Tokyo, Japan), the cells were 121
treated with 30 mg/ml lysozyme dissolved in a 25% (w/v) solution of sucrose, at 37°C 122
for 1 h. Molecular cloning in E. coli was conducted as described elsewhere (44). 123
Plasmid DNA from E. coli was prepared using a QIAprep Miniprep kit (Qiagen, 124
Hilden, Germany). Plasmids were purified from B. longum cells as described 125
previously (27). PCR was performed using PrimeSTAR HS DNA polymerase with GC 126
Buffer (Takara Bio) according to the manufacturer’s instructions. Amplified DNA 127
fragments were purified using a MinElute PCR purification kit (Qiagen) or a MinElute 128
gel extraction kit (Qiagen). Agarose gel electrophoresis was conducted as described 129
previously (13). Nucleotide sequences were determined by the dideoxy method at 130
Takara Bio and Operon Biotechnologies, Inc. (Tokyo, Japan). BLAST programs were 131
used for sequence similarity analysis (1). Southern hybridization analysis was 132
conducted as described previously (13). BamHI-digested chromosomal DNA (4 µg) 133
from each strain was analyzed. The 3′ region of aga (1.1 kbp) was amplified from 134
pBS423-ΔrepAΔaga with the primer pair aga13f/aga8r and used as a probe. 135
136
Electro-transformation of B. longum strains. Electro-transformation of B. 137
longum was performed using a previously described method with some modifications 138
(3). In brief, B. longum 105-A and first-crossover integrants were cultured 139
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
7
anaerobically until the OD660 reached 0.5 to 0.6 in 1/2 MRSCS medium and 1/2 140
MRSCS-Spc medium, respectively, both of which were supplemented with 50 mM 141
sucrose. Cells were then harvested by centrifugation at 32,300 × g at 4°C for 15 min 142
and washed twice with ice-cold buffered sucrose (1 mM ammonium citrate buffer 143
containing 50 mM sucrose, pH 6.0) and resuspended in the buffered sucrose. 144
Electroporation was conducted using Gene Pulser (Bio-Rad Laboratories, Hercules, 145
CA) in the settings of 12 kV/cm, 25 μF and 200 Ω. After an electric pulse, the cells 146
were cultured anaerobically in 1/2 MRSCS supplemented with 50 mM sucrose for 3 h 147
and spread onto 1/2 MRSCS agar medium (without sucrose supplementation) 148
containing antibiotics corresponding to the plasmid used. The plates were incubated 149
anaerobically at 37°C for 48 h. Sucrose in the 1/2 MRSCS medium and the buffered 150
sucrose has been reported to improve the transformation efficiency in bifidobacteria 151
(3). 152
153
Construction of incompatible plasmids for markerless gene deletion. Two 154
incompatible plasmids, pBS423-ΔrepA and pTBR101-CM, were constructed for 155
markerless gene deletion. All of the plasmids named below were constructed by the 156
introduction of ligated products into E. coli HMS174 (8) and subsequent selection on 157
LB agar medium containing appropriate antibiotics. To construct pBS423-ΔrepA, a 158
conditional replication vector for the first crossover event, the Spc resistance (Spcr) 159
gene [Spc adenyltransferase AAD(9)] from pBRASTA101 (48) was first ligated with a 160
pMB1 ori-containing fragment from pUC18. The resulting plasmid was named 161
pTANS19. The cryptic plasmid pTB4 from B. longum BK25 (13) was digested with 162
BamHI and ligated into pTANS19. The resulting plasmid, E. coli-Bifidobacterium 163
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
8
shuttle vector pBS423 (Fig. 2A), was digested with HincII to remove repA. The 164
HincII-digested pBS423 was separated into 4.4-kbp and 0.5-kbp fragments (the latter 165
contained a part of repA), and the 4.4-kbp fragment was self-ligated. The resulting 166
plasmid was named pBS423-ΔrepA [RepA-, pTB4 ori+, Spcr (Fig. 2B)] and was 167
shown not to replicate in B. longum 105-A. 168
To construct pTBR101-CM, a repA-positive plasmid for facilitation of the second 169
crossover step, bifidobacterial plasmid pTB4 was purified from B. longum BK25, 170
digested with BamHI, and ligated into BamHI-digested pBR322. The resulting plasmid, 171
E. coli-Bifidobacterium shuttle vector pTBR101 (Fig. 2C), was digested with HindIII. 172
The HindIII linker fragment was ligated to the MspI-Sau3AI-digested DNA fragment 173
from pC194 containing the Cm resistance (Cmr) gene (18). The HindIII-digested 174
fragment containing the Cmr gene was ligated into HindIII-digested pTBR101, and the 175
resulting plasmid was named pTBR101-CM [RepA+, pTB4 ori+, Cmr (Fig. 2D)]. 176
Nucleotide sequences of the plasmids constructed were deposited into the 177
DDBJ/EMBL/GenBank databases (Accession no. AB687999 for pBS423 including the 178
information of deleted region in pBS423-ΔrepA and AB688000 for pTBR101-CM). 179
180
Construction of vectors for the first crossover. Two first-crossover vectors were 181
constructed for different objectives: pBS423-ΔrepAβgal for validation of the 182
integration and efficient excision/exclusion of the vector at the βgal locus and 183
pBS423-ΔrepAΔaga for introduction of the markerless gene deletion in aga locus. 184
For the construction of pBS423-ΔrepAβgal, the full-length βgal of B. longum 185
105-A, which shows 99% nucleotide identity to BLLJ_1486 in B. longum subsp. 186
longum JCM 1217T (15), was used as the target gene. A 4.6-kbp fragment containing 187
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
9
full-length βgal was amplified by PCR, using B. longum 105-A chromosomal DNA as 188
a template and the lacZ Fw/lacZ Rv primer pair. The amplified product was digested 189
with PstI and ligated into PstI-digested pBS423-ΔrepA. Ligated products were 190
introduced into E. coli JM109 by electroporation. Transformants were selected on LB 191
agar containing Spc and supplemented with X-Gal 192
(5-bromo-4-chloro-3-indolyl-β-D-galactoside; 40 µg/ml) and IPTG 193
(isopropyl-1-thio-β-D-galactopyranoside; 0.1 mM). Colonies that showed blue color, 194
indicating successful cloning of βgal, were isolated. 195
For the construction of pBS423-ΔrepAΔaga, the 5′ and 3′ regions of aga, but 196
lacking the internal region of aga containing the predicted α-Gal catalytic site (Fig. 197
3A), were used for the construction. A 4.9-kbp fragment containing the full-length aga 198
gene was amplified by PCR using B. longum 105-A chromosomal DNA as the template 199
and the aga1f/aga2r oligonucleotide primer pair. The amplified fragment was purified 200
and cloned into TA-cloning vector pGEM-T Easy (Promega Corp., Madison, WI). The 201
resulting plasmid was named pGEM-T-aga. The 5′ and 3′ regions of the cloned 202
fragment (0.9 and 1.1 kbp, respectively) were separately amplified by PCR using 203
pGEM-T-aga as the template and aga11f/aga12r and aga13f/aga8r as the respective 204
primer pairs. These fragments were fused together by performing a second 205
amplification, covering the 25-bp overlapping region inserted at the 5′ terminus of the 206
primer aga13f, with the aga11f/aga8r primer pair. The amplified 2.0-kbp fragment was 207
digested with PstI and ligated into PstI-digested pBS423-ΔrepA. The ligated products 208
were introduced into E. coli JM109 and transformants were selected on LB-Spc agar 209
medium. 210
211
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
10
Construction of the first-crossover integrants. The first-crossover integrants 212
were constructed by the introduction of the first-crossover vectors, either 213
pBS423-ΔrepAβgal or pBS423-ΔrepAΔaga, to B. longum 105-A by electroporation. 214
Transformants were selected on 1/2 MRSCS-Spc agar medium. Integration of the 215
first-crossover vector into objective gene locus was verified by genomic PCR using 216
following primers: pBS423-ΔrepAβgal integrants, SpR1/SpR3 and 217
bgal1/UC18pBS423 (Fig. S1A) for the detection of the Spcr gene and 218
pBS423-ΔrepAβgal integration sequence, respectively; pBS423-ΔrepAΔaga integrants, 219
aga11f/aga8r, aga11f/TB4-1 and aga8r/SpR4 (Fig. 3A) for the detection of the 220
pBS423-ΔrepAΔaga integration sequence. The validated strains were used as the 221
first-crossover integrant of each vector. 222
223
Triggering of the second crossover by the introduction of pTBR101-CM. 224
pTBR101-CM was introduced into the first-crossover integrant, either 105-A 225
βgal::pBS423-ΔrepAβgal or 105-A aga::pBS423-ΔrepAΔaga, by electroporation to 226
facilitate the second crossover step through excision of integrated 227
pBS423-ΔrepA-derived first-crossover vectors. Transformants were selected on 1/2 228
MRSCS-Cm agar medium as the Cm-resistant colonies, and they were anaerobically 229
subcultured overnight in 1/2 MRSCS-Cm medium. Subcultures were conducted twice. 230
Excised plasmid was expected to be eliminated from the cells due to plasmid 231
incompatibility during the subcultures. Second-crossover recombinants were selected 232
by using Spc sensitive (Spcs) phenotype as an indicator of the elimination of the 233
excised plasmid. This was tested by a replica-plating method using 1/2 MRSCS-Cm 234
and 1/2 MRSCS-CmSpc agar media. Excision of pBS423-ΔrepA-derived first 235
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
11
crossover vectors was verified by genomic PCR using the following primer pairs: for 236
pBS423-ΔrepAβgal, SpR1/SpR3 and bgal1/UC18pBS423; for pBS423-ΔrepAΔaga, 237
aga11f/aga8r, aga11f/TB4-1 and aga8r/SpR4. In principle, the second crossover event 238
in 105-A βgal::pBS423-ΔrepAβgal yields original wild-type 105-A strain with respect 239
to βgal allele and that in 105-A aga::pBS423-ΔrepAΔaga yields either wild-type 240
revertant or mutant with respect to aga allele. In order to check if the recombination 241
rates actually change when pTBR101-CM is introduced into the cell, control 242
experiments were conducted in both the first-crossover integrants without adding 243
pTBR101-CM in the reaction mixture for electroporation step (mock transformation 244
experiment) for comparison. In this case Cm was not added to the culture media. 245
246
Construction of the markerless aga-defective mutants. The second-crossover 247
recombinants from 105-A aga::pBS423-ΔrepAΔaga was cultured in SSM 248
supplemented with raffinose as the sole carbohydrate source using 96-well microtiter 249
plates. Strains that showed no growth were selected as candidates for aga deletion. The 250
genotypes of the candidates were checked by aga-specific PCR, conducted using 251
chromosomal DNA as the template and the aga11f/aga8r primer pair. Subsequently, 252
one candidate was cultured anaerobically overnight in 1/2 MRSCS-Rif broth at 37°C to 253
cure pTBR101-CM, which was propagated in the cells. The culture was streaked onto 254
1/2 MRSCS agar medium. Plasmid-cured strains were selected as Cm-sensitive (Cms) 255
colonies by replica plating using 1/2 MRSCS and 1/2 MRSCS-Cm agar media. After 256
curing, detailed genotype analysis of the candidate aga-deletion strain was conducted 257
by Southern hybridization and sequencing of the aga-deletion region. The aga-deletion 258
mutant was named 105-A Δaga. 259
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
12
260
Construction of the aga-complemented strain. The upstream region of aga 261
containing the putative promoter was determined from the draft genome sequence of B. 262
longum 105-A (Yoshikawa et al., unpublished result) and a previous report (21). A 263
2.5-kbp DNA fragment containing aga and an upstream region (135 bp) was amplified 264
by PCR using pGEM-T-aga as the template and the aga20f/aga21r primer pair. The 265
products were digested with SalI and ligated into SalI-digested pKKT427 (51) (Spcr). 266
The ligated products were introduced into E. coli DH5α and transformants were 267
selected on LB-Spc agar medium. The resulting aga-complementation plasmid was 268
named pAga135. Purified pAga135 was subsequently introduced into 105-A Δaga by 269
electroporation, and a Spc-resistant strain was isolated on 1/2 MRSCS-Spc agar 270
medium. Propagation of pAga135 was confirmed by agarose gel electrophoresis of the 271
purified plasmid. The strain, named 105-A Δaga/pAga135, was used as a 272
plasmid-based aga-complemented strain. An empty vector-introduced strain, 105-A 273
Δaga/pKKT427, was similarly constructed through introduction of the shuttle vector 274
pKKT427 into 105-A Δaga. 275
276
Measurement of α-Gal activity. Strains 105-A, 105-A Δaga, 105-A 277
Δaga/pAga135 and 105-A Δaga/pKKT427 were cultured overnight in 40 ml of 1/2 278
MRSCS (Spc was added when necessary). Cells were harvested by centrifugation at 279
19,000 × g at 4°C for 15 min and washed with saline. The cells were resuspended in 280
SSM containing 20 g/L raffinose and incubated for 6 h under anaerobic conditions at 281
37°C to induce α-Gal expression. The cells were harvested by centrifugation, washed 282
twice with ice-cold 50 mM potassium phosphate buffer (pH 6.0) containing 0.015% 283
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
13
(w/v) dithiothreitol, and disrupted three times using a French pressure cell (Ohtake 284
Works, Tokyo, Japan) at 125 MPa. Cell debris was removed by centrifugation. The 285
resulting supernatant was used as a crude extract. Protein concentration was 286
determined by the Bradford method using a Bio-Rad protein assay kit (Bio-Rad 287
Laboratories, Hercules, CA). Measurement of α-Gal activity was performed according 288
to a previously described method (36) in a 300 µl of reaction mixture containing 50 289
mM potassium phosphate buffer (pH 6.0), 5 mM p-nitrophenyl-α-D-galactopyranoside 290
(25026-81; Nacalai Tesque, Inc., Kyoto, Japan) (as a substrate), and 60 µl of crude 291
extract, diluted appropriately in 50 mM potassium phosphate buffer (pH 6.0) 292
containing 0.5 mg/ml bovine serum albumin. The enzyme reaction was started by 293
adding the crude extract to the reaction mixture followed by incubation at 35°C for 5 294
or 10 min. The reaction was stopped by adding 600 µl of 1M Na2CO3. A blank reaction 295
mixture was prepared by adding 600 µl of 1M Na2CO3 prior to the addition of the 296
crude extract. The release of p-nitrophenol was monitored in a 1-cm-wide cuvette by 297
measuring absorbance at 400 nm with a DU800 spectrophotometer (Beckman Coulter 298
Inc., Fullerton, CA). The absorbance value for the blank was subtracted from that for 299
the samples. A molar extinction coefficient of 5,560 M-1 cm-1 for p-nitrophenol was 300
used in the calculation. The specific activity was expressed as µmol of p-nitrophenol 301
per min per mg protein. 302
303
RESULTS 304
Validation of the proposed system at β-galactosidase gene locus in B. longum 305
105-A. In the proposed system, the plasmid pBS423-ΔrepA (RepA-, pTB4 ori+, Spcr), 306
which lacks the gene encoding the replication protein RepA, was used as the 307
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
14
conditional replication vector. A second plasmid, pTBR101-CM (RepA+, pTB4 ori+, 308
Cmr), which was incompatible with pBS423-ΔrepA, was used to supply RepA. 309
Uncertainty as to the presence of sufficient recombination activity in B. longum 105-A 310
led us to first examine whether integration and excision events readily occur, using 311
full-length βgal as the target. 312
Spcr transformants carrying the pBS423-ΔrepAβgal were obtained with an 313
efficiency of 50 cfu/μg DNA. Genomic PCR analysis of the isolated transformants 314
indicated that pBS423-ΔrepAβgal was successfully integrated into the chromosomal 315
βgal locus as a result of the first crossover (Supplemental Fig. S1B and C). 316
Introduction of pTBR101-CM into the first-crossover pBS423-ΔrepAβgal integrants 317
yielded transformants (7.5 × 102 cfu/μg DNA) on 1/2 MRSCS-Cm agar. After 318
subsequent culture of pTBR101-CM transformants in 1/2 MRSCS-Cm medium, 100% 319
of the colonies tested showed Spcs (Table 2). In contrast, only 0.125% of the mock 320
transformants without using pTBR101-CM showed Spcs phenotype after the culture in 321
1/2 MRSCS medium. Therefore, it was found that the introduction of pTBR101-CM 322
dramatically increased the frequency of appearance of the second-crossover 323
recombinants. 324
No amplification in genomic PCR analysis of selected Spcs strains (Supplemental 325
Fig. S1D and E) indicated successful excision of the pBS423-ΔrepAβgal from the 326
chromosome by the second crossover. To confirm elimination of the excised 327
pBS423-ΔrepA by using incompatibility, plasmids in the second-crossover 328
recombinants were extracted and introduced into E. coli DH5α. Many transformants 329
derived from pTBR101-CM appeared in the LB-Cm agar. In contrast, none of the 330
transformants derived from pBS423-ΔrepA were detected in LB-Spc agar. These 331
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
15
results indicate that the excised pBS423-ΔrepA was eliminated from cells because of 332
plasmid incompatibility. Taken together, the proposed system was verified to function 333
as expected. 334
335
Markerless deletion of aga in B. longum 105-A. This system was next applied for 336
markerless gene deletion into the aga gene, which putatively encodes α-Gal (Fig. 3A). 337
The α-Gal-encoding gene was selected as the target because α-Gal hydrolyzes raffinose, 338
which is known to increase bifidobacterial populations in the intestinal tract of rats and 339
humans (9, 10). As shown in Table 3, three genes annotated as α-Gal were found in the 340
draft genome sequence of B. longum 105-A (Yoshikawa et al., unpublished data). The 341
contribution of each gene to the α-Gal activity in B. longum 105-A cells was not 342
known. Among these genes, aga and galA3 are conserved in the genomes of B. longum 343
NCC2705 and B. longum DJO10A (Table 3). Furthermore, the molecular weight of the 344
deduced aga polypeptide was similar to those of purified α-Gals from other 345
bifidobacteria (approximately 80 kDa as a monomer) (16, 24, 49). Therefore, aga was 346
inferred to contribute to α-Gal activity and raffinose assimilation in B. longum 105-A. 347
Fragments of both the 5′ and 3′ regions of aga (each approximately 1 kbp in 348
length), which lacked the sequence for the putative active site of the protein, were used 349
as the homologous regions to construct the conditional replication vector 350
pBS423-ΔrepAΔaga. Outline of experimental procedures is illustrated in Fig. 3A. 351
When pBS423-ΔrepAΔaga was introduced into B. longum 105-A by electroporation, 352
Spcr transformants were formed with an efficiency of 2.2 × 102 cfu/μg DNA. After 353
single colony isolation, strains harboring pBS423-ΔrepAΔaga integrated into the 354
chromosomal aga locus were selected by aga-specific PCR (primer pair aga11f/aga8r). 355
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
16
The amplicons of both wild-type (3.4 kbp) and mutant (2.0 kbp) aga alleles were 356
identified in Spcr transformants (Fig. 3B). In order to identify integration patterns, PCR 357
was conducted using different primer pairs. Amplicons of 3.8 kbp (primer pair 358
aga11f/TB4-1, Fig. 3C) and 2.2 kbp (primer pair aga8r/SpR4, Fig. 3D) were detected 359
in the same transformants. These results demonstrated that the selected strains were 360
first-crossover integrants of pBS423-ΔrepAΔaga (105-A aga::pBS423-ΔrepAΔaga) in 361
which recombination had taken place in the 3′ region of the aga locus (region B, Fig. 362
3A). 363
To construct the markerless aga-deletion mutants, pTBR101-CM was introduced 364
into the 105-A aga::pBS423-ΔrepAΔaga, and Cmr transformants were formed with an 365
average efficiency of 3.9 × 102 cfu/μg DNA. Randomly selected Cmr transformants 366
(288 colonies) were subcultured in 1/2 MRSCS-Cm broth to select for 367
second-crossover recombinants. The subcultures were checked for Spcs and the 368
inability to assimilate raffinose by the replica method. The results indicated a high 369
frequency of appearance of the second-crossover recombinants, as 270 of the 288 370
subcultured strains were Spcs (94%). In this case, four of the 270 Spcs strains (1.5%) 371
lacked raffinose assimilation ability and were thus considered candidate aga-deletion 372
mutants. Genotype analysis of all of these candidates by aga-specific PCR supported 373
their inability to grow on raffinose (data not shown). In addition, same aga-specific 374
PCR analysis of raffinose-assimilating Spcs strains indicated that these strains were the 375
revertants to wild-type aga allele (data not shown). In a separate experiment, 376
usefulness of pTBR101-CM was also confirmed at the aga locus. As shown in Table 2 377
when pTBR101-CM was not introduced into the integrant, the ratio of Spcs colonies 378
among the tested colonies was found to be dramatically decreased, indicating the 379
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
17
facilitation of the second crossover step by the plasmid. One of the four candidate 380
strains was selected and used to cure pTBR101-CM, which remained in the cells. Rif 381
was employed as a curing agent because it was previously used to cure plasmids in E. 382
coli (6, 30). After Rif treatment, 84% of the colonies grown on 1/2 MRSCS agar plates 383
showed Cms. Curing of the plasmid was also confirmed by the introduction of the 384
extracted plasmid fraction from a Cms strain into E. coli, which yielded no Cmr E. coli 385
transformants. These results indicated that pTBR101-CM was successfully removed 386
from the candidate strain by Rif treatment. Deletion of aga from the 387
pTBR101-CM-cured candidate strain was further confirmed by Southern hybridization 388
(Fig. 3E) and sequence analysis. These results demonstrated successful markerless aga 389
gene deletion in B. longum 105-A. This mutant was named 105-A Δaga. 390
391
Functional analyses of aga using B. longum 105-A Δaga. To clarify the function 392
of aga, complementation of aga in 105-A Δaga was conducted using the plasmid 393
pAga135, which harbors the aga ORF and a 135-bp upstream region containing the 394
putative aga promoter. A transformant, 105-A Δaga/pAga135, was used in the 395
functional analysis, together with the wild-type 105-A strain, 105-A Δaga, and the 396
empty vector-introduced derivative 105-A Δaga/pKKT427. 397
Carbohydrate assimilation analysis using SSM revealed that 105-A Δaga was 398
unable to grow after cultivation for 24 h on either melibiose or raffinose, two substrates 399
for α-Gal (Fig. 4). In contrast, Δaga/pAga135 showed comparable growth levels to 400
105-A on all tested carbohydrates. These results indicated that aga is the gene 401
responsible for the assimilation of melibiose and raffinose. 402
Next, α-Gal activity was measured in cells incubated for 6 h in SSM containing 403
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
18
raffinose as the sole carbohydrate. As expected, α-Gal activity was not detected in 404
105-A Δaga (Table 4). α-Gal activity was successfully restored in Δaga/pAga135 but 405
not in 105-A Δaga/pKKT427 (Table 4). Taken together, these results clearly identify 406
aga as the only functional α-Gal gene necessary for the assimilation of α-galactosides 407
such as melibiose and raffinose in B. longum 105-A. These results also suggest that the 408
other annotated α-Gal genes in the B. longum 105-A genome, galA2 and galA3 (Table 409
3), make little contribution, if any, to α-Gal activity under the conditions used in this 410
study. 411
412
DISCUSSION 413
In this study, a markerless gene deletion system was successfully developed using a 414
double-crossover method in B. longum 105-A. Despite the emerging importance of 415
bifidobacteria in human health, genetic manipulation systems for improving our 416
understanding of these bacteria, especially efficient methods for targeted gene 417
mutagenesis, have not yet been established. Several B. breve UCC2003 gene-insertion 418
mutants (32-34, 41), in which a non-replicating vector containing internal DNA 419
fragments of the target gene was integrated into the target gene by a single crossover 420
method, were recently reported. A mutant of B. longum NCC2705 has also been 421
generated (15). In this mutant, gene disruption was achieved by a double-crossover 422
method in which a region homologous to the target gene along with an inserted 423
antibiotic resistance gene was cloned into a general E. coli vector, and allelic exchange 424
was performed. These methods represent important progress in the function analysis of 425
bifidobacterial genes, although exogenous sequences (vector sequences and/or 426
selection marker genes) were left in the mutated allele with both methods. In contrast, 427
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
19
the proposed method is a markerless deletion method that does not leave any 428
exogenous sequences in the mutated allele. 429
The following factors are considered to be the characteristics of the developed 430
system. (i) Facilitation of the second crossover step. A low-frequency second crossover 431
event is generally the bottleneck in gene mutagenesis based on the double-crossover 432
system. In this study, a conditional replication vector lacking repA [pBS423-ΔrepA 433
(Spcr)] for integration into the chromosome (first crossover event) and a second 434
plasmid to supply RepA (pTBR101-CM) were used to facilitate the second crossover 435
step. As shown in Table 2, pTBR101-CM apparently increased the second crossover 436
frequency. Still one can also consider the possibility that the introduced pTBR101-CM 437
served simply as a strong selective pressure to the first-crossover integrants allowing 438
the preferential growth of pre-existing spontaneous second-crossover recombinants 439
after the electro-transformation step. However, this may not be the case as there 440
seemed to be no contamination of the spontaneous second-crossover recombinants in 441
the competent cells (Spc was included in the medium for preparation of the competent 442
cells). Though not shown in the results, colony PCR analysis of the pTBR101-CM 443
transformants clearly indicated that the excision of the integrated plasmid from the 444
chromosome had already occurred in the transformed colonies before subcultures. 445
Taken together, the supply of RepA was judged to increase the second crossover 446
frequency, which led to the facilitation of the second crossover step. 447
(ii) Exclusion of excised vector by plasmid incompatibility. Plasmid incompatibility 448
has been used as a method to eliminate unnecessary plasmids from cells during 449
bacterial gene mutagenesis by double-crossover recombination (11, 25, 37, 43). This 450
system was applied to markerless gene deletion. The use of two incompatible vectors, 451
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
20
pBS423-ΔrepA and pTBR101-CM, enabled the excised vector pBS423-ΔrepA 452
(containing a wild-type or mutated allele) to be effectively excluded from cells. In 453
principle, either plasmid could be excluded. However, in this case, retaining 454
pTBR101-CM was the only option because pBS423-ΔrepA cannot replicate on its own. 455
The Spcs plus Cmr combination ensured acquisition of the desired recombinants. 456
(iii) Successful curing of pTBR101-CM by Rif. The remaining pTBR101-CM in 457
cells was easily cured by Rif treatment, as has been reported in E. coli (6, 30). 458
Successful curing of the replicative vector in the markerless gene deletion mutant 459
means that multiple gene deletions are possible using the developed system. Multiple 460
gene mutations have not been introduced into bifidobacteria and are theoretically 461
limited with mutagenesis methods that leave antibiotic resistance markers such as Spc 462
(29), tetracycline (2), and erythromycin (42) in the mutated allele, owing to the limited 463
availability of these makers in bifidobacteria. 464
Temperature-sensitive vectors harboring temperature-sensitive rep gene have been 465
commonly used for targeted gene mutagenesis in other bacteria (7, 17, 35, 45). 466
However, no reliable temperature-sensitive vector is currently available for use in 467
bifidobacteria. In addition, mutagenic effects of heat shock stress on the genome 468
sequence are concerned, because heat shock-induced GroEL/GroES chaperone is 469
known to protect error-prone DNA polymerases, Pol IV and Pol V, from degradation in 470
E. coli (12). Homologs of the chaperone and the DNA polymerases are also found in 471
the genome sequences of B. longum 105-A and other bifidobacteria. 472
Theoretically, after the introduction of gene mutations by the double-crossover 473
method, the frequencies of the appearance of the wild-type and the mutant genotypes 474
should be the same. However, it was found that the number of aga-deletion mutants 475
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
21
was far lower than that of revertants (4 vs. 266). The reason for the low frequency of 476
gene deletion mutants is unclear, but it is possible that there was a difference in 477
recombination efficiency between the homologous regions A and B used in aga 478
deletion (Fig. 3A). Therefore, the recombination frequency was checked using 479
plasmids consisting of homologous region A or B in pBS423-ΔrepA. These plasmids 480
were introduced into B. longum 105-A, and the appearance of first-crossover integrants 481
was examined. However, no significant difference between homologous regions A and 482
B was observed (data not shown). These results suggest that a difference in 483
recombination frequency between these homologous regions was not a cause of the 484
low occurrence of gene deletion mutants. An unexpected selective disadvantage 485
associated with the aga deletion might be involved in this tendency. Further 486
comparisons using other genes are needed to address this point. 487
The aga was shown to be the sole responsible gene for α-Gal activity in B. longum 488
105-A. Successful complementation in both the growth on melibiose and the α-Gal 489
enzyme activity by introduction of pAga135 into α-Gal-deficient E. coli JW4080 490
(melA-) also supported the observation (data not shown). Although gene deletion 491
mutants for the other annotated α-Gal genes (galA2 and galA3) were not constructed, it 492
seemed that these genes are either not expressed or do not encode proteins with α-Gal 493
activity. The nucleotide similarity between aga and galA2 or galA3 was calculated to 494
be 47% or 48%, respectively. The molecular weights of the predicted polypeptides 495
encoded by these genes were lower than that of aga (Table 3) and those of purified 496
α-Gals in other bifidobacteria (approximately 80 kDa) (16, 24, 49), suggesting that 497
these genes are unlikely to encode proteins with α-Gal activity. 498
The applicability of the developed system to other bifidobacterial species is unclear. 499
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
22
It may depend on the host range of the plasmids pBS423-ΔrepA and pTBR101-CM, 500
both of which were derived from a cryptic plasmid pTB4 harbored by B. longum BK25 501
(13). Another factor will be the transformation efficiency of a given bifidobacterial 502
strain. The average transformation efficiency of an E. coli-Bifidobacterium shuttle 503
vector pBS423 into B. longum 105-A was 1.1 × 105 cfu/μg DNA, whereas in the case 504
of aga deletion, transformation efficiency of pBS423-ΔrepAΔaga for the construction 505
of the first crossover integrants decreased to 2.2 × 102 cfu/μg DNA. The average 506
transformation efficiency of the replicative pTBR101-CM vector into the 507
first-crossover integrants was 3.9 × 102 cfu/μg DNA. According to our calculation, 508
from previously reported data on host/vector systems, the median transformation 509
efficiency in bifidobacteria was up to 103 cfu/μg DNA (14). It therefore appears that 510
application of the developed system to other bifidobacteria will be limited to the strains 511
that have relatively high transformation efficiency at least over 104 cfu/μg DNA with 512
the replicative vector pBS423. In fact, preliminary trials for the deletion of aga in B. 513
longum subsp. longum JCM 1217T, B. longum subsp. infantis JCM 1222T and B. breve 514
JCM 1192T were not successful probably due to the low-transformation efficiencies as 515
well as appearance of false-positive transformants. Optimization of transformation 516
conditions and antibiotic concentrations for transformants selection will allow the 517
markerless gene deletion in other strains. Methylation of the vectors using 518
bifidobacterial modification enzymes is one way to increase the transformation 519
efficiency by avoiding cleavage of introduced DNA by restriction system in 520
bifidobacteria (33, 51). 521
The markerless gene deletion method reported here can be used for functional gene 522
analysis as well as for other applications. For example, this method may have 523
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
23
advantages in the construction of food-grade host strains, as the use of antibiotic 524
resistance genes has not been approved for the construction of food-grade hosts (40, 525
45). Moreover, the method may be used to insert exogenous genes into the 526
bifidobacterial chromosome. It is anticipated that therapeutic proteins and hormones 527
for medical treatments could be stably expressed in genetically engineered 528
bifidobacteria (14). 529
In conclusion, a rational system for markerless gene deletion was successfully 530
developed in B. longum 105-A. Although the applicability of this system to other 531
bifidobacteria remains to be demonstrated, and there is much room for improvement, 532
we believe that this technique will accelerate functional gene analysis in bifidobacteria. 533
534
535
ACKNOWLEDGMENTS 536
We are grateful to Masayuki Okuyama (Research Faculty of Agriculture, Hokkaido 537
University) for the instruction of the α-galactosidase activity measurement. This study 538
was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan 539
Society for the Promotion of Science (No. 23780072 to S.F.), by a Grant-in-Aid for 540
Regional R&D Proposal-Based Program Grant from Northern Advancement Center for 541
Science & Technology of Hokkaido Japan (No. T-3-5 to S.F.), and by a Ph.D. Student 542
Research Support Program Grant from Hokkaido University Clark Memorial 543
Foundation to Y.H. We also thank the Research Center, Nippon Beet Sugar Mfg. Co., 544
Ltd. (Obihiro, Japan) for financial support. 545
546
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
24
REFERENCES 547
1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local 548
alignment search tool. J. Mol. Biol. 215:403-410. 549
2. Álvarez-Martín P, Belén Flórez A, Margolles A, del Solar G, Mayo B. 2008. 550
Improved cloning vectors for bifidobacteria, based on the Bifidobacterium 551
catenulatum pBC1 replicon. Appl. Environ. Microbiol. 74:4656-4665. 552
3. Argnani A, Leer RJ, van Luijk N, Pouwels PH. 1996. A convenient and 553
reproducible method to genetically transform bacteria of the genus 554
Bifidobacterium. Microbiology 142:109-114. 555
4. Barrangou R, Briczinski EP, Traeger LL, Loquasto JR, Richards M, 556
Horvath P, Coûté-Monvoisin AC, Leyer G, Rendulic S, Steele JL, 557
Broadbent JR, Oberg T, Dudley EG, Schuster S, Romero DA, Roberts RF. 558
2009. Comparison of the complete genome sequences of Bifidobacterium 559
animalis subsp. lactis DSM 10140 and Bl-04. J. Bacteriol. 191:4144-4151. 560
5. Barrett AR, Kang Y, Inamasu KS, Son MS, Vukovich JM, Hoang TT. 2008. 561
Genetic tools for allelic replacement in Burkholderia species. Appl. Environ. 562
Microbiol. 74:4498-4508. 563
6. Bazzicalupo P, Tocchini-Valentini GP. 1972. Curing of an Escherichia coli 564
episome by rifampicin (acridine orange/F+/F-/Hfr/lac). Proc. Natl. Acad. Sci. U. 565
S. A. 69:298-300. 566
7. Biswas I, Gruss A, Ehrlich SD, Maguin E. 1993. High-efficiency gene 567
inactivation and replacement system for gram-positive bacteria. J. Bacteriol. 568
175:3628-3635. 569
8. Campbell JL, Richardson CC, Studier FW. 1978. Genetic recombination and 570
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
25
complementation between bacteriophage T7 and cloned fragments of T7 DNA. 571
Proc. Natl. Acad. Sci. U. S. A. 75:2276-2280. 572
9. Dinoto A, Marques TM, Sakamoto K, Fukiya S, Watanabe J, Ito S, Yokota 573
A. 2006. Population dynamics of Bifidobacterium species in human feces 574
during raffinose administration monitored by fluorescence in situ 575
hybridization-flow cytometry. Appl. Environ. Microbiol. 72:7739-7747. 576
10. Dinoto A, Suksomcheep A, Ishizuka S, Kimura H, Hanada S, Kamagata Y, 577
Asano K, Tomita F, Yokota A. 2006. Modulation of rat cecal microbiota by 578
administration of raffinose and encapsulated Bifidobacterium breve. Appl. 579
Environ. Microbiol. 72:784-792. 580
11. Fedorova ND, Highlander SK. 1997. Generation of targeted nonpolar gene 581
insertions and operon fusions in Pasteurella haemolytica and creation of a 582
strain that produces and secretes inactive leukotoxin. Infect. Immun. 583
65:2593-2598. 584
12. Foster PL. 2007. Stress-induced mutagenesis in bacteria. Crit. Rev. Biochem. 585
Mol. Biol. 42:373-397. 586
13. Fukiya S, Sugiyama T, Kano Y, Yokota A. 2010. Characterization of an 587
insertion sequence-like element, ISBlo15, identified in a size-increased cryptic 588
plasmid pBK283 in Bifidobacterium longum BK28. J. Biosci. Bioeng. 589
110:141-146. 590
14. Fukiya S, Suzuki T, Kano Y, Yokota A. 2011. Current status of 591
Bifidobacterium gene manipulation technologies, p 33-51. In Sonomoto K, 592
Yokota A (ed), Lactic acid bacteria and bifidobacteria: Current progress in 593
advanced research. Caister Academic Press, Norfolk, UK. 594
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
26
15. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, 595
Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, 596
Hattori M, Ohno H. 2011. Bifidobacteria can protect from enteropathogenic 597
infection through production of acetate. Nature 469:543-547. 598
16. Goulas T, Goulas A, Tzortzis G, Gibson GR. 2009. A novel α-galactosidase 599
from Bifidobacterium bifidum with transgalactosylating properties: gene 600
molecular cloning and heterologous expression. Appl. Microbiol. Biotechnol. 601
82:471-477. 602
17. Hamilton CM, Aldea M, Washburn BK, Babitzke P, Kushner SR. 1989. 603
New method for generating deletions and gene replacements in Escherichia 604
coli. J. Bacteriol. 171:4617-4622. 605
18. Horinouchi S, Weisblum B. 1982. Nucleotide sequence and functional map of 606
pC194, a plasmid that specifies inducible chloramphenicol resistance. J. 607
Bacteriol. 150:815-825. 608
19. Ichimura M, Nakayama-Imaohji H, Wakimoto S, Morita H, Hayashi T, 609
Kuwahara T. 2010. Efficient electrotransformation of Bacteroides fragilis. 610
Appl. Environ. Microbiol. 76:3325-3332. 611
20. Kleerebezem M, Vaughan EE. 2009. Probiotic and gut lactobacilli and 612
bifidobacteria: molecular approaches to study diversity and activity. Annu. Rev. 613
Microbiol. 63:269-290. 614
21. Klijn A, Moine D, Delley M, Mercenier A, Arigoni F, Pridmore RD. 2006. 615
Construction of a reporter vector for the analysis of Bifidobacterium longum 616
promoters. Appl. Environ. Microbiol. 72:7401-7405. 617
22. Kurdi P, Kawanishi K, Mizutani K, Yokota A. 2006. Mechanism of growth 618
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
27
inhibition by free bile acids in lactobacilli and bifidobacteria. J. Bacteriol. 619
188:1979-1986. 620
23. Leahy SC, Higgins DG, Fitzgerald GF, van Sinderen D. 2005. Getting better 621
with bifidobacteria. J. Appl. Microbiol. 98:1303-1315. 622
24. Leder S, Hartmeier W, Marx SP. 1999. α-Galactosidase of Bifidobacterium 623
adolescentis DSM 20083. Curr. Microbiol. 38:101-106. 624
25. Lee CA, Saier MH Jr. 1983. Use of cloned mtl genes of Escherichia coli to 625
introduce mtl deletion mutations into the chromosome. J. Bacteriol. 626
153:685-692. 627
26. Lee JH, Karamychev VN, Kozyavkin SA, Mills D, Pavlov AR, Pavlova NV, 628
Polouchine NN, Richardson PM, Shakhova VV, Slesarev AI, Weimer B, 629
O’Sullivan DJ. 2008. Comparative genomic analysis of the gut bacterium 630
Bifidobacterium longum reveals loci susceptible to deletion during pure culture 631
growth. BMC Genomics 9:247. 632
27. Lee JH, O’Sullivan DJ. 2006. Sequence analysis of two cryptic plasmids from 633
Bifidobacterium longum DJO10A and construction of a shuttle cloning vector. 634
Appl. Environ. Microbiol. 72:527-535. 635
28. Leenhouts K, Buist G, Bolhuis A, ten Berge A, Kiel J, Mierau I, 636
Dabrowska M, Venema G, Kok J. 1996. A general system for generating 637
unlabelled gene replacements in bacterial chromosomes. Mol. Gen. Genet. 638
253:217-224. 639
29. Matsumura H, Takeuchi A, Kano Y. 1997. Construction of Escherichia 640
coli-Bifidobacterium longum shuttle vector transforming B. longum 105-A and 641
108-A. Biosci. Biotechnol. Biochem. 61:1211-1212. 642
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
28
30. Messing J, Staudenbauer WL, Hofschneider PH. 1972. Inhibition of 643
minicircular DNA replication in Escherichia coli 15 by rifampicin. Nat. New 644
Biol. 238:202-203. 645
31. Mizoguchi H, Tanaka-Masuda K, Mori H. 2007. A simple method for 646
multiple modification of the Escherichia coli K-12 chromosome. Biosci. 647
Biotechnol. Biochem. 71:2905-2911. 648
32. O’Connell Motherway M, Fitzgerald GF, Neirynck S, Ryan S, Steidler L, 649
van Sinderen D. 2008. Characterization of ApuB, an extracellular type II 650
amylopullulanase from Bifidobacterium breve UCC2003. Appl. Environ. 651
Microbiol. 74:6271-6279. 652
33. O’Connell Motherway M, O’Driscoll J, Fitzgerald GF, van Sinderen D. 653
2009. Overcoming the restriction barrier to plasmid transformation and targeted 654
mutagenesis in Bifidobacterium breve UCC2003. Microb. Biotechnol. 655
2:321-332. 656
34. O’Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, 657
Claesson MJ, O’Brien F, Flynn K, Casey PG, Moreno Munoz JA, Kearney 658
B, Houston AM, O’Mahony C, Higgins DG, Shanahan F, Palva A, de Vos 659
WM, Fitzgerald GF, Ventura M, O’Toole PW, van Sinderen D. 2011. 660
Functional genome analysis of Bifidobacterium breve UCC2003 reveals type 661
IVb tight adherence (Tad) pili as an essential and conserved host-colonization 662
factor. Proc. Natl. Acad. Sci. U. S. A. 108:11217-11222. 663
35. Okibe N, Suzuki N, Inui M, Yukawa H. 2011. Efficient markerless gene 664
replacement in Corynebacterium glutamicum using a new 665
temperature-sensitive plasmid. J. Microbiol. Methods 85:155-163. 666
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
29
36. Okuyama M, Kitamura M, Hondoh H, Kang MS, Mori H, Kimura A, 667
Tanaka I, Yao M. 2009. Catalytic mechanism of retaining α-galactosidase 668
belonging to glycoside hydrolase family 97. J. Mol. Biol. 392:1232-1241 669
37. Ostroff RM, Vasil ML. 1987. Identification of a new phospholipase C activity 670
by analysis of an insertional mutation in the hemolytic phospholipase C 671
structural gene of Pseudomonas aeruginosa. J. Bacteriol. 169:4597-4601. 672
38. Pavelka MS Jr, Jacobs WR Jr. 1999. Comparison of the construction of 673
unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium 674
bovis Bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by 675
allelic exchange. J. Bacteriol. 181:4780-4789. 676
39. Perrin S, Warchol M, Grill JP, Schneider F. 2001. Fermentations of 677
fructo-oligosaccharides and their components by Bifidobacterium infantis 678
ATCC 15697 on batch culture in semi-synthetic medium. J. Appl. Microbiol. 679
90:859-865. 680
40. Peterbauer C, Maischberger T, Haltrich D. 2011. Food-grade gene 681
expression in lactic acid bacteria. Biotechnol. J. 6:1147-1161. 682
41. Pokusaeva K, O’Connell Motherway M, Zomer A, MacSharry J, 683
Fitzgerald GF, van Sinderen D. 2011. Cellodextrin utilization by 684
Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 77:1681-1690. 685
42. Rossi M, Brigidi P, Gonzalez Vara y Rodriguez A, Matteuzzi D. 1996. 686
Characterization of the plasmid pMB1 from Bifidobacterium longum and its 687
use for shuttle vector construction. Res. Microbiol. 147:133-143. 688
43. Ruvkun GB, Ausubel FM. 1981. A general method for site-directed 689
mutagenesis in prokaryotes. Nature 289:85-88. 690
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
30
44. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory 691
manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 692
NY. 693
45. Sasaki Y, Ito Y, Sasaki T. 2004. thyA as a selection marker in construction of 694
food-grade host-vector and integration systems for Streptococcus thermophilus. 695
Appl. Environ. Microbiol. 70:1858-1864. 696
46. Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, 697
Zwahlen MC, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F. 2002. 698
The genome sequence of Bifidobacterium longum reflects its adaptation to the 699
human gastrointestinal tract. Proc. Natl. Acad. Sci. U. S. A. 99:14422-14427. 700
47. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus 701
A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills 702
DA. 2008. The genome sequence of Bifidobacterium longum subsp. infantis 703
reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. 704
Acad. Sci. U. S. A. 105:18964-18969. 705
48. Tanaka K, Samura K, Kano Y. 2005. Structural and functional analysis of 706
pTB6 from Bifidobacterium longum. Biosci. Biotechnol. Biochem. 69:422-425. 707
49. Xiao M, Tanaka K, Qian XM, Yamamoto K, Kumagai H. 2000. High-yield 708
production and characterization of α-galactosidase from Bifidobacterium breve 709
grown on raffinose. Biotechnol. Lett. 22:747-751. 710
50. Xie Z, Okinaga T, Qi F, Zhang Z, Merritt J. 2011. Cloning-independent and 711
counterselectable markerless mutagenesis system in Streptococcus mutans. 712
Appl. Environ. Microbiol. 77:8025-8033. 713
51. Yasui K, Kano Y, Tanaka K, Watanabe K, Shimizu-Kadota M, Yoshikawa 714
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
31
H, Suzuki T. 2009. Improvement of bacterial transformation efficiency using 715
plasmid artificial modification. Nucleic Acids Res. 37:e3. 716
717
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
32
Figure legends 718
FIG. 1. Outline of markerless gene deletion system in Bifidobacterium longum 719
105-A. GeneA represents a model target gene for markerless gene deletion. ΔGeneA 720
lacks the internal region of GeneA and is cloned in the conditional replication vector 721
(first plasmid), which lacks the repA gene encoding the plasmid replication initiation 722
protein RepA (indicated as ΔrepA). The region absent in ΔGeneA is identified by a 723
cross. Theoretically two types of GeneA alleles can be generated by the first crossover 724
and ΔGeneA deletion mutants and wild-type revertants can arise in the 725
second-crossover recombinants. Here only the simplified scheme for generation of 726
ΔGeneA deletion mutants was described to represent the concept. 1) First crossover. 727
The first plasmid harboring ΔGeneA was introduced into the host strain B. longum 728
105-A. Here the 5′ region of ΔGeneA is used as a homologous region for the first 729
crossover. The first-crossover integrant harbors both the GeneA and ΔGeneA alleles in 730
its chromosome. The region derived from the first plasmid harboring ΔGeneA in the 731
chromosome of the first-crossover integrants is identified by a dashed line. 2) 732
Transformation of the RepA+ plasmid. Introduction of the repA-harboring second 733
plasmid (RepA+ plasmid) into the first-crossover integrant results in the supply of the 734
plasmid replication protein RepA to the cells. 3) Second crossover and excision. 735
Integrated first plasmid is expected to be excised with GeneA from the chromosome as 736
a result of the second crossover event facilitated by RepA. 4) Exclusion. The excised 737
first plasmid with GeneA has been excluded due to the incompatibility between two 738
plasmids. Objective ΔGeneA deletion mutants can be found among the 739
second-crossover recombinants. Abbreviations: AntAr, resistance gene for antibiotic A; 740
AntBr, resistance gene for antibiotic B. 741
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
33
FIG. 2. Structures of the plasmids used in markerless gene deletion. Genes are 742
identified by open arrows except for the repA gene identified by black arrows. 743
Representative restriction sites in the plasmids are shown. DNA regions in plasmids 744
pBS423 (A), pTBR101 (C), and pTBR101-CM (D) are shown in the surrounding circle 745
(dashed lines) of each plasmid and are divided according to the source of the DNA 746
region. Names of derived genetic materials are shown on the surrounding circle. The E. 747
coli-Bifidobacterium shuttle vector pBS423 (A) was constructed by cloning the cryptic 748
plasmid pTB4 from B. longum BK25 into the BamHI site of pTANS19. The 749
conditional replication vector pBS423-ΔrepA (B) was constructed by 750
self-circularization of the 4.4-kbp HincII-fragment of pBS423. Because pBS423-ΔrepA 751
lacks the repA gene, which encodes the replication initiation protein RepA, it cannot 752
replicate in B. longum 105-A. To construct pTBR101-CM (D), which is incompatible 753
with pBS423-ΔrepA, a chloramphenicol resistance gene (Cmr) from pC194 (cryptic 754
plasmid of Staphylococcus aureus) was cloned into the HindIII site of pTBR101 (C), 755
which consists of pTB4 from B. longum BK25 and pBR322. Spcr, spectinomycin 756
resistance gene; Apr, ampicillin resistance gene. 757
758
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
34
FIG. 3. (A) Schematic of the markerless gene deletion procedures conducted in B. 759
longum 105-A. The first crossover event is shown in the upper panel, and the second 760
crossover event is in the lower panel. The first crossover between the target gene (aga) 761
and the conditional replication vector pBS423-ΔrepAΔaga harboring the Δaga allele, 762
which lacks the internal region of aga (C in the chromosome structure), can take place 763
with homologous region A or B, yielding two types of first-crossover integrants, a) and 764
b). Primers used to check the genotypes of first-crossover integrants are shown as open 765
arrows, with names above the predicted structure of the target locus of each 766
first-crossover integrant. The expected lengths of the amplicons generated using these 767
primers are indicated by dashed lines below the predicted structures. The second 768
crossover event, facilitated by the supply of RepA by the plasmid pTBR101-CM, can 769
take place with homologous region A or B in the first-crossover integrants, a) and b). 770
The second crossover event yielded two types of strains: 1) aga-deletion mutants, and 771
2) wild-type revertants. Predicted restriction sites for BamHI and the predicted lengths 772
of the restriction fragments are indicated in the structure of the aga locus for each 773
strain. (B), (C), and (D) Genotype analyses of the pBS423-ΔrepAΔaga transformants to 774
confirm integration of pBS423-ΔrepAΔaga into the aga locus. Amplified fragments 775
produced using the aga11f/aga8r primer pair (B), the aga11f/TB4-1 primer pair (C), 776
and the SpR4/aga8r primer pair (D), were subjected to agarose gel electrophoresis. A 1 777
kb DNA ladder (New England Biolabs, Inc., Ipswich, MA) was used as a molecular 778
weight marker (lane M). The sizes of representative marker fragments are shown to the 779
left of each panel. Each lane shows amplified DNA generated from a DNA template: 780
lanes 1-8, candidate first-crossover integrants; lane P, pBS423-ΔrepAΔaga (positive 781
control for amplification); lane W, B. longum 105-A (wild-type); lane N, no template 782
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
35
DNA (negative control for amplification). The sizes of the amplified fragments are 783
shown to the right of each panel. (E) Southern hybridization analysis of markerless aga 784
deletion. Samples of BamHI-digested chromosomal DNA (4 μg) were electrophoresed 785
in a 0.7% agarose gel. Each lane corresponds to a DNA sample from a Bifidobacterium 786
strain: lane 1, B. longum 105-A; lane 2, 105-A Δaga; lane 3, wild-type revertant (after 787
the second crossover). Electrophoresed total DNA was transferred to a nylon 788
membrane. The 3′ region of aga (region B in FIG. 3A) was used as a probe. 789
Hybridization signals were detected after exposure for 30 min. The sizes of the 790
hybridized fragments are indicated to the left of the panel.791
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
36
FIG. 4. Growth profiles of the B. longum strains 105-A, 105-A Δaga, 105-A 792
Δaga/pAga135 and 105-A Δaga/pKKT427. Bacteria were cultured anaerobically at 793
37°C for 24 h in semi-synthetic medium containing glucose (filled bars), raffinose 794
(gray bars), or melibiose (open bars) as the sole carbohydrate source. Striped bars 795
indicate cultures without addition of carbohydrate source. Data are shown as means ± 796
SE of three independent experiments. 797
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
TABLE 1 Bacterial strains and plasmids used in this studyStrain or plasmid Descriptiona ReferenceEscherichia coli strainsDH5 F-,80lacZM15, lacZYA-argF)U169, recA1, endA1, hsdR17rk
-,mk+), phoA, supE44, -, thi-1, Invitrogen
gyrA96, relA1HMS174 F-, -, recA1, INrrnD-rrnE)1, rph-1, rpoB331R), hsdR19 8JM109 recA1, endA1, gyrA96, thi, hsdR17rk
-, mk+), e14 - mcrA -), supE44, relA1, lac-proAB)/F'[traD36, Takara Bio Inc.
proAB+, lacIq, lacZM15]Bifidobacterium longum strains105-A Human fecal isolate, transformation host strain 29105-A gal::pBS423-repAgal First-crossover integrant of pBS423-repAgal into chromosomal - gal) locus This study105-A aga::pBS423-repAaga First-crossover integrant of pBS423-repAaga into chromosomal - aga) locus This study105-A aga aga-deletion mutant of 105-A This study105-A aga/pAga135 Plasmid-based aga-complementation strain of 105-A by introduction of pAga135 This study105-A aga/pKKT427 -introduced derivative of 105-A This studyBK25 Human fecal isolate harboring cryptic plasmid pTB4 13
PlasmidspAga135 6.4 kbp, pKKT427-derivative containing aga and 135-bp upstream region including putative aga promoter, This study
Spcr
pBS423 4.9 kbp, E. coli-Bifidobacterium shuttle vector, pMB1 ori, pTB4 ori, repA+, Spcr This studypBS423-repA 4.4 kbp, pTB4 ori, repA, Spcr This studypBS423-repAaga 6.2 kbp, derivative of pBS423- containing integrated fragment of 5' and 3' regions of aga, Spcr This studypBS423-repAgal 9.0 kbp, derivative of pBS423-repA containing - gal), Spcr This studypBR322 4.4 kbp, E. coli cloning vector, rop, Tcr, Apr Takara Bio Inc.pBRASTA101 5.0 kbp, E. coli-Bifidobacterium shuttle vector, pMB1 ori, pTB6 ori, Spcr 48pC194 2.9 kbp, Small R-plasmid found in Staphylococcus aureus, Cmr 18pGEM-T Easy 3.0 kbp, TA cloning vector, Apr Promega Corp.pGEM-T-aga 7.9 kbp, 4.9 kbp of B. longum 105-A genomic DNA fragment containing aga was cloned in pGEM-T Easy This studypKKT427 3.9 kbp, E. coli-Bifidobacterium shuttle vector, ColE1 ori, pTB6 ori, Spcr 51pTANS19 1.9 kbp, E. coli cloning vector, pMB1 ori, Spcr This studypTB4 2.9 kbp, Cryptic plasmid in B. longum BK25 This studypTBR101 7.3 kbp, E. coli-Bifidobacterium shuttle vector, pMB1 ori, pTB4 ori, repA+, Apr effective only in E. coli This studypTBR101-CM 8.4 kbp, Cmr gene cloned in pTBR101, pMB1 ori, pTB4 ori, repA+, Apr effective only in E. coli This study
a Antibiotic resistance genes in plasmids were abbreviated as follows: Apr, Ampicillin resistance; Cmr, Chloramphenicol resistance; Spcr, Spectinomycin resistance; Tcr, Tetracycline resistance.
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
TABLE 2 Frequency of detection of Spcs colonies during the culture of first-crossover integrants
First-crossover integrant
Addition of pTBR101-CMto reaction mixture for
electroporation
Number of tested
Number of Spcs
second-crossover
Percentage 100)
105-A gal::pBS423-repAgal
- 2396 3 0.125+ 3568 3568 100
105-A aga::pBS423-repAaga
- 963 1 0.104+ 1645 1643 99.9
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
TABLE 3 Annotated -galactosidase genes in B. longum 105-A draft genome and their distribution in other B. longum strains, NCC2705 and DJO10AB. longum strain
105-A NCC2705 DJO10A
Annotated -Gala
gene in 105-ALength of
Calculated MWb
Nucleotide sequence identityc
Annotated -Gala
geneNucleotide sequence
identityc Annotated -Gala
geneNucleotide sequence
identityc
aga galA1) 2,307 83.3 100 aga) 98.1 galA1) 99.0galA2 1,863 68.1 100 NDd NDd galA2) 99.8galA3 1,410 52.4 100 BL_0177 98.7 galA3) 99.5
a -Gal, -galactosidase. b Molecular weight of deduced polypeptide was calculated.c !"#!$ % &"'((&&"!-Gal gene in B. longum 105-A.d ND, not determined because galA2 homolog was absent in B. longum NCC2705.
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from
TABLE 4 -Galactosidase activities of B. longum 105-A and its derivativesStrain Specific activitya
105-A 4.44 0.36105-A aga Not detected105-A aga/pAga135 1.30 0.09105-A aga/pKKT427 Not detecteda The activities were measured after induction by raffinose as described in -galactosidase specific activity [molmin-1 protein)-1] with standard error as determined in duplicate on three biological replicates.
on Decem
ber 13, 2020 by guesthttp://aem
.asm.org/
Dow
nloaded from